G-protein-coupled receptors (GPCRs) are one of the largest families of cell surface proteins in the human body that recognize hormones, neurotransmitters, and drugs. These receptors regulate a wide ...

PAXTON, Ill. (WCIA) — A former Paxton pharmacist is going to be taking a plea deal after she was accused of illegally ...

Despite the availability of effective antihypertensive therapies, global blood pressure control rates remain unacceptably low. Contributing factors, such as low treatment adherence, therapeutic ...

Arizona-based Strive Compounding Pharmacy has sued Eli Lilly (LLY) and Novo Nordisk (NVO) in a Texas federal court alleging that the drug giants coordinated to stifle competition by hindering access ...

The President claimed in a rare primetime Oval Office address that the economy is doing well and will boom in 2026. Will it persuade the public? Plus Paul Gigot and Matthew Continetti on Trump's best ...

The compounding program is designed to elevate pharmacy technicians to nationally recognized training standards. “Compounding pharmacies thrive when their teams operate at the top of their training ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The pharmacy argued in its ...

If you knew a medicine wasn’t regulated or reviewed by the U.S. Food and Drug Administration, would you still be willing to take it? My guess is that most people wouldn’t willingly put an unknown ...

The rule will restrict pharmacies to producing batches of no more than 250 units for sterile injectable drugs, including popular weight-loss drug copies. This change could impact telehealth companies ...

Forbes contributors publish independent expert analyses and insights. Sally Pipes is a scholar and think tank CEO who writes on health care. "The booming trade in illicit GLP-1s deserves a swift ...

Sterile compounding has long been recognized as a high-risk area of health system pharmacy. Traditional manual IV compounding techniques can be prone to human error, leading to incorrect ingredients ...

The FDA says shortages of GLP-1s are over, but many patients are still getting what are essentially copied medications. The market for drugs that treat obesity and help people lose weight is soaring.